Regenerative discovery
EVs and enabling platforms for researchers studying regeneration and tissue biology.
THE GENEFRONT PLATFORMS
From source-cell selection and optimized media to engineered EVs and sustained-release formulations, our work supports regenerative discovery and application development.
OUR CORE PLATFORMS
EV production is the foundation. Engineering and sustained-release formulations extend what researchers can investigate.

Human iPSC- and MSC-derived EVs, optimized production processes, and proprietary culture media developed to increase production capacity.
Explore EV productionEngineered EVs for biomolecule delivery research, guided by cargo, target organ, and intended application.
03 / SUSTAINED RELEASEGeneFront-developed EV formulations for sustained release and research into longer-term, organ-targeted biomolecule delivery.
FROM CULTURE TO CHARACTERIZATION
3D human iPSC culture and MSC expansion and EV-collection workflows. Discuss proprietary media, defined or serum-free culture needs, and production-process requirements.
Human iPSC- and MSC-derived EV platforms form the starting point for regenerative discovery. Source-cell choice and intended research use guide the production discussion.
EV collection and downstream processing connect production with the particle, marker, purity, and lot-documentation requirements of the study.
Discuss project-specific formats, specifications, current availability, and supporting documentation with GeneFront.
WHERE THE WORK CAN LEAD
Supporting researchers today while developing EV platforms for future therapeutic, diagnostic, and cosmetic applications.
EVs and enabling platforms for researchers studying regeneration and tissue biology.
Research into engineered EVs and delivery of biomolecules for future therapeutic applications.
EV-associated molecular signals and cell-specific capture tools for disease-related research.
EV formulation development for skin, scalp, and cosmetic research.
START A CONVERSATION
Connect with GeneFront about products, technical information, research collaborations, or investment and partnership discussions.